Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Akcea Therapeutics, Inc.    AKCA

AKCEA THERAPEUTICS, INC.

(AKCA)
  Report
SummaryQuotesChartsNewsRatingsCompanyFinancials 
Valuation
Fiscal Period: December 2017 2018 2019
Capitalization1 1 1552 6901 591
Entreprise Value (EV)1 1 1552 4421 143
P/E ratio -5,64x-10,5x59,2x
Yield ---
Capitalization / Revenue 26,6x41,5x3,26x
EV / Revenue 26,6x37,6x2,34x
EV / EBITDA -9,61x-10,8x25,5x
Price to Book -9,73x3,15x
Nbr of stocks (in thousands) 66 54289 25993 901
Reference price (USD) 17,430,116,9
Last update 03/02/202003/02/202003/02/2020
1
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net sales ---43,464,9489
EBITDA1 -29,9-61,3-83,4-120-22544,7
Operating profit (EBIT)1 -30,0-61,4-83,5-120-22938,1
Operating Margin ----278%-353%7,79%
Pre-Tax Profit (EBT)1 -30,0-61,4-83,2-120-22543,0
Net income1 -30,0-61,4-83,2-122-22640,8
Net margin ----280%-348%8,35%
EPS ----3,08-2,870,29
Dividend per Share ------
Last update 05/09/201702/28/201803/01/201903/02/202003/02/202003/02/2020
1 USD in Million
Balance Sheet Analysis
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net Debt ------
Net Cash position ----248448
Leverage (Debt / EBITDA) ----1,10x-10,0x
Free Cash Flow ---25,4-4,07-1128,33
ROE (Net Profit / Equities) --216%-444%-162%-102%9,95%
Shareholders' equity1 -28,418,875,0222410
ROA (Net Profit / Asset) --114%-136%-53,9%-45,1%4,93%
Assets1 -54,161,2226501826
Book Value Per Share ----3,105,38
Cash Flow per Share ----0,973,04
Capex -0,010,180,011,121,60
Capex / Sales ---0,02%1,73%0,33%
Last update 05/09/201702/28/201803/01/201903/02/202003/02/202003/02/2020
1 USD in Million
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
1 848 975 057
Net sales (USD)
488 543 000
Number of employees
294
Sales / Employee (USD)
1 661 711
Free-Float
17,2%
Free-Float capitalization (USD)
317 120 025
EPS & Dividend